Evidence map›Paper›PMID 35110363›Full record

Observational studyJournal of the American Society of Nephrology : JASN2022

The Impact of Vaccination on Incidence and Outcomes of SARS-CoV-2 Infection in Patients with Kidney Failure in Scotland.

Samira Bell, Jacqueline Campbell, Emilie Lambourg, Chrissie Watters, Martin O'Neil, Alison Almond, Katharine Buck, Edward J Carr, Laura Clark, Zoe Cousland and 10 more

Erratum issuedOpen access · greenAbstract readObservational Study
In one paragraph

Observational study in Journal of the American Society of Nephrology : JASN, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 35 papers.

0numbers the graph read from it
0cells of the map it votes in
35citing papers in PubMed
4.9field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

35 citing papers in PubMed, 49 citations in OpenAlex.

  1. Efficacy and Safety of Remdesivir in People With Impaired Kidney Function Hospitalized for COVID-19 Pneumonia: A Randomized Clinical Trial.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America · 2024
    Trial
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. COVID-19 and cardiovascular disease in patients with chronic kidney disease.Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association · 2024
    Review
  10. Article
  11. Article
  12. Reduction in the risk of progression of solid organ transplant recipients infected by SARS-CoV-2 treated with monoclonal antibodies.Revista espanola de quimioterapia : publicacion oficial de la Sociedad Espanola de Quimioterapia · 2023
    Review
  13. Oral antiviral therapies for COVID-19 in patients with advanced chronic kidney disease or kidney failure.Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association · 2023
    Article
  14. Article
  15. Review
  16. Article
  17. Clinical manifestations of COVID-19 infection in dialysis patients and protective effect of COVID-19 vaccine.Inflammation research : official journal of the European Histamine Research Society ... [et al.] · 2023
    Review
  18. Article
  19. Article
  20. Excess Mortality in Kidney and Kidney-Pancreas Transplant Recipients in the COVID-19 Pandemic in Portugal-A Cohort Study.Transplant international : official journal of the European Society for Organ Transplantation · 2023
    Observational
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

20 authors at 11 institutions in 2 countries.

Samira BellDivision of Population Health and Genomics, School of Medicine, University of Dundee, Dundee, Scotland.ORCID 0000-0001-9100-1575
Jacqueline CampbellThe Scottish Renal Registry, Scottish Health Audits, Public Health Scotland, Glasgow, Scotland.
Emilie LambourgDivision of Population Health and Genomics, School of Medicine, University of Dundee, Dundee, Scotland.
Chrissie WattersThe Scottish Renal Registry, Scottish Health Audits, Public Health Scotland, Glasgow, Scotland.
Martin O'NeilThe Scottish Renal Registry, Scottish Health Audits, Public Health Scotland, Glasgow, Scotland.
Alison AlmondRenal Unit, Mountainhall Treatment Centre, Dumfries, Scotland.
Katharine BuckRenal Unit, Victoria Hospital, Kirkcaldy, Scotland.
Edward J CarrDivision of Population Health and Genomics, School of Medicine, University of Dundee, Dundee, Scotland.ORCID 0000-0001-9343-4593
Laura ClarkDepartment of Renal Medicine, Foresterhill Health Campus, Aberdeen Royal Infirmary, Aberdeen, Scotland.
Zoe CouslandRenal Unit, Monklands Hospital, Airdrie, Scotland.
Mark FindlayGlasgow Renal & Transplant Unit, Queen Elizabeth University Hospital, Glasgow, Scotland.
Nicola JossRenal Unit, Raigmore Hospital, Inverness, Scotland.
Wendy MetcalfeDepartment of Renal Medicine, Royal Infirmary of Edinburgh, Edinburgh Bioquarter, Edinburgh, Scotland.
Michaela PetrieDepartment of Renal Medicine, Royal Infirmary of Edinburgh, Edinburgh Bioquarter, Edinburgh, Scotland.
Elaine SpaldingRenal Unit, University Hospital Crosshouse, Crosshouse, Scotland.
Jamie P TraynorGlasgow Renal & Transplant Unit, Queen Elizabeth University Hospital, Glasgow, Scotland.ORCID 0000-0002-4339-0366
Vinod SanuRenal Unit, Ninewells Hospital, Dundee, Scotland.
Peter ThomsonGlasgow Renal & Transplant Unit, Queen Elizabeth University Hospital, Glasgow, Scotland.
Shona MethvenDepartment of Renal Medicine, Foresterhill Health Campus, Aberdeen Royal Infirmary, Aberdeen, Scotland.
Patrick B MarkGlasgow Renal & Transplant Unit, Queen Elizabeth University Hospital, Glasgow, Scotland.ORCID 0000-0003-3387-2123
Queen Elizabeth University Hospital · GBPublic Health Scotland · GBUniversity of Dundee · GBAberdeen Royal Infirmary · GBEdinburgh Royal Infirmary · GBMonklands Hospital · GBNHS Dumfries and Galloway · GBNinewells Hospital · GBRaigmore Hospital · GBUniversity Hospital Crosshouse · GBVictoria Hospital · IN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundPatients with kidney failure requiring KRT are at high risk of complications and death following SARS-CoV-2 infection, with variable antibody responses to vaccination reported. We investigated the effects of COVID-19 vaccination on the incidence of infection, hospitalization, and death from COVID-19 infection.

methodsThe study design was an observational data linkage cohort study. Multiple health care datasets were linked to ascertain all SARS-CoV-2 testing, vaccination, hospitalization, and mortality data for all patients treated with KRT in Scotland from the start of the pandemic over a period of 20 months. Descriptive statistics, survival analyses, and vaccine effectiveness were calculated.

resultsAs of September 19, 2021, 93% (

conclusionsThese data demonstrate that a primary vaccine course of two doses has limited effect on COVID-19 infection and its complications in patients with KRT. Adjunctive strategies to reduce risk of both COVID-19 infection and its complications in this population are urgently required.

Indexed as

COVID-19Renal InsufficiencyCohort StudiesCOVID-19 TestingCOVID-19 VaccinesHumansIncidenceSARS-CoV-2ScotlandVaccinationCOVID-19 Vaccinesclinical epidemiologyCOVID-19dialysiskidney replacement therapytransplantationvaccination

Identifiers

PMID35110363
PMCPMC8970454
OpenAlexW4220711305

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.